Anti-cyclic citrullinated peptide autoantibodies in IgM rheumatoid factor-positive patients

This publication has 24 references indexed in Scilit:

• Autoantibodies to citrullinated proteins in rheumatoid arthritis: clinical performance and biochemical aspects of an RA-specific marker
  Clinica Chimica Acta; International Journal of Clinical Chemistry, 2004
• Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: A prospective cohort study
  Arthritis & Rheumatism, 2004
• Specific autoantibodies precede the symptoms of rheumatoid arthritis: A study of serial measurements in blood donors
  Arthritis & Rheumatism, 2004
• Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis
  Annals of the Rheumatic Diseases, 2003
• Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage
  Annals of the Rheumatic Diseases, 2003
• How to diagnose rheumatoid arthritis early: A prediction model for persistent (erosive) arthritis
  Arthritis & Rheumatism, 2002
• Rheumatoid arthritis
  Published by Elsevier ,2001
• The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis
  Arthritis & Rheumatism, 2000
• The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide
  Arthritis & Rheumatism, 2000
• Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.
  Journal of Clinical Investigation, 1998